Report

Peptide Antagonists of the Human Estrogen Receptor

Science  30 Jul 1999:
Vol. 285, Issue 5428, pp. 744-746
DOI: 10.1126/science.285.5428.744

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Estrogen receptor α transcriptional activity is regulated by distinct conformational states that are the result of ligand binding. Phage display was used to identify peptides that interact specifically with either estradiol- or tamoxifen-activated estrogen receptor α. When these peptides were coexpressed with estrogen receptor α in cells, they functioned as ligand-specific antagonists, indicating that estradiol-agonist and tamoxifen–partial agonist activities do not occur by the same mechanism. The ability to regulate estrogen receptor α transcriptional activity by targeting sites outside of the ligand-binding pocket has implications for the development of estrogen receptor α antagonists for the treatment of tamoxifen-refractory breast cancers.

  • * To whom correspondence should be addressed. E-mail: mcdon016{at}acpub.duke.edu

View Full Text

Related Content